Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected for Jawline Contouring

LG Chem

Status

Completed

Conditions

Jaw Volume Deficit

Treatments

Device: YVOIRE Y-Solution 720

Study type

Interventional

Funder types

Industry

Identifiers

NCT04886544

LG-HACL025

Details and patient eligibility

About

A Multicenter, Evaluator-Blinded, No-Treatment Control Design Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected for Jawline Contouring

Full description

This is a Multicenter, Randomized, Evaluator-Blinded, No-Treatment Control Design Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected for Jawline Contouring.

Enrollment

72 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Male or female adults 18 - 75 years of age (inclusive)
2 (moderate) or 3 (severe) on Jawline Contour Rating Scale (JCRS)
want a filler injection procedure for the replacement of volume loss in the jawlines

Exclusion criteria

have an active or infective skin disease
have lower-face volume deficit due to congenital defect, trauma, abnormalities in adipose tissue related to immune-mediated diseases
have a tattoo or excessive facial hair in the evaluation area
have received permanent facial implants
have undergone semi-permanent filler within 24 months
have undergone temporary dermal filler treatment in the lower face (below the orbital rim) within 12 months
have streptococcal disease
have a medical history of hypertrophic cicatrix, hyperpigmentation or keloid
have a history of anaphylaxis, multiple severe allergies, or allergy to lidocaine (or any amide-based anesthetic), or hyaluronic acid products
have history of bleeding disorder
have severe cardiovascular, hepatic or renal diseases considered as per Investigator's discretion
have known malignant tumors or cancerous or precancerous lesion
positive pregnancy test indicating pregnancy
active COVID-19 infection and suspected COVID-19 infection within the past 14 days